Hearing Loss in Parkinson's Disease: A Systematic Review and Meta‐Analysis
Movement Disorders · 2026-05 · 41 (5) · 1069-1080
DOI: 10.1002/mds.70206 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Movement Disorders, online erschienen am 30.01.2026. Verfasst von Shahryar Rajai Firouzabadi und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Hearing Loss, Parkinson Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 65 Literaturangaben.
Abstract (Originalsprache)
Background
Hearing loss is increasingly recognized as a non‐motor manifestation of Parkinson's disease (PD), but its prevalence, characteristics, and underlying mechanisms remain unclear. This systematic review aims to evaluate the prevalence and characteristics of hearing loss in people with PD (PwPD).
Methods
PubMed, Embase, and Web of Science were searched without restrictions. Observational studies assessing hearing loss in PwPD using pure tone audiometry (PTA), speech audiometry (SA), or central auditory processing (CAP) tests were included. Random‐effects models were applied, and heterogeneity was examined by meta‐regression.
Results
Thirty‐five studies encompassing 1316 PwPD and 820 controls were included. Pooled prevalence indicated 73.9% (95% CI: 61.5%, 84.8%) of 1009 PwPD had hearing loss, with high‐frequency impairment (82.6%) more common than low‐frequency loss (45.1%). Compared with age matched controls, PwPD were 1.82 times more likely to experience hearing loss (odds ratio = 1.82; 95% CI: 1.19–2.78; PwPD = 599; healthy controls = 579). Older age and higher‐frequency testing predicted higher prevalence. SA results were inconsistent. CAP meta‐analyses revealed significant prolongation of brain stem auditory‐evoked potential wave III latency (standardized mean difference [SMD] = 0.51; 95% CI: 0.15–0.88), wave V latency (SMD = 0.73; 95% CI: 0.25–1.21), and I–V interpeak interval (SMD = 0.84; 95% CI: 0.41–1.27). Among late latency potentials, N200 latency (SMD = 0.60; 95% CI: 0.20–0.99) and P300 latency (SMD = 0.73; 95% CI: 0.49–0.98) were significantly delayed, while other components showed no group differences.
Conclusions
Hearing loss is common in PD, extending beyond age‐related decline and likely involving both peripheral and central pathways. It may represent an early non‐motor symptom and a marker of cognitive vulnerability. © 2026 International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Shahryar Rajai Firouzabadi, Ida Mohammadi, Hossein Golsorkh, Sara Sadeghzadeh, Kamran Rezaei, Mehri Salari
Zitieren
APA
Rajai Firouzabadi, S., Mohammadi, I., Golsorkh, H., Mahdavi, S., Sadeghzadeh, S., Rezaei, K., & Salari, M. (2026). Hearing Loss in Parkinson's Disease: A Systematic Review and Meta‐Analysis. Movement Disorders, 41(5), 1069-1080. https://doi.org/10.1002/mds.70206
Vancouver
Rajai Firouzabadi S, Mohammadi I, Golsorkh H, Mahdavi S, Sadeghzadeh S, Rezaei K, et al. Hearing Loss in Parkinson's Disease: A Systematic Review and Meta‐Analysis. Movement Disorders. 2026;41(5):1069-1080. doi:10.1002/mds.70206
BibTeX
@article{RajaiFirouzabadi2026,
author = {Rajai Firouzabadi, Shahryar and Mohammadi, Ida and Golsorkh, Hossein and Mahdavi, Sajjad and Sadeghzadeh, Sara and Rezaei, Kamran and Salari, Mehri},
title = {Hearing Loss in Parkinson's Disease: A Systematic Review and Meta‐Analysis},
journal = {Movement Disorders},
year = {2026},
volume = {41},
number = {5},
pages = {1069--1080},
doi = {10.1002/mds.70206}
}
EUVIMED